Search Results - roy+wuthier

3 Results

Sort By:

Use of FC101 as an Anti-Angiogenesis Lead Compound for Developing Chemotherapeutic Agents for Cancer and Other Angiogenic Diseases.

Reference #: 00124 Invention Description: The subject invention describes the use of Fusarochromanone (FC101), a fungal metabolite known to cause avian tibial dyschondroplasia. FC101 is an inhibitor of angiogenesis, lymphocytic development, and importantly the proliferation of many human cancer cell lines. FC101 has highly selective action, inhibiting...

Published: 9/2/2022 | Inventor(s): Roy Wuthier, Daotai Nie

Keywords(s):

Category(s): Biomedical and Life Sciences, Health Sciences

Light Induced Activation of Fusarochromanone and its Derivatives for their Use in the Diagnosis and Treatment of Cancer

Reference #: 00718 The University of South Carolina is offering licensing opportunities for an exciting advancement in cancer treatment. Fusarochromanone is a photodynamic therapy that targets cancer cells without destroying healthy cells. It is effective in low doses and has limited side effects. Potential Applications: Fusarochromanone can be used...

Published: 4/4/2017 | Inventor(s): Brian Furmanski, John Fuseler, Roy Wuthier

Keywords(s):

Category(s): Biomedical and Life Sciences

Discovery of Direct Growth Inhibition of Various Types of Cancer Cells by Fusarochromanone

Reference #: 00337 The University of South Carolina is offering sub-licensing opportunities for a compound that shows promise for the treatment of cancer, arthritis, and other angiogenic diseases. The compound strongly inhibits tumor growth and is also effective in inhibiting angiogenesis. This unique combination of anticancer activity and anti-angiogenic...

Published: 9/2/2022 | Inventor(s): Daotai Nie, Roy Wuthier, Licia Wu, Brian Genge

Keywords(s):

Category(s): Biomedical and Life Sciences